ProKidney (MEX:PROK) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Days Payable?

ProKidney's average Accounts Payable for the three months ended in Mar. 2024 was MXN71.28 Mil. ProKidney's Cost of Goods Sold for the three months ended in Mar. 2024 was MXN0.00 Mil.

The historical rank and industry rank for ProKidney's Days Payable or its related term are showing as below:

MEX:PROK's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.78
* Ranked among companies with meaningful Days Payable only.

ProKidney's Days Payable stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00). stayed the same

ProKidney Days Payable Historical Data

The historical data trend for ProKidney's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Days Payable Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Payable

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of ProKidney's Days Payable

For the Biotechnology subindustry, ProKidney's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProKidney's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProKidney's Days Payable distribution charts can be found below:

* The bar in red indicates where ProKidney's Days Payable falls into.

ProKidney Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

ProKidney's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (59.346	+	86.535)	/	2 )	/	0	*	365
=	72.9405					/	0	*	365
=	N/A

ProKidney's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (86.535	+	56.029)	/	2 )	/	0	*	365 / 4
=	71.282					/	0	*	365 / 4
=	N/A

ProKidney Days Payable Related Terms

Thank you for viewing the detailed overview of ProKidney's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney (MEX:PROK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.